p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
about
A Genetic-Pathophysiological Framework for CraniosynostosisGenetic insights into the mechanisms of Fgf signalingCraniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant miceMorphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models.Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses.The effect of a Beare-Stevenson syndrome Fgfr2 Y394C mutation on early craniofacial bone volume and relative bone mineral density in mice.The role of vertebrate models in understanding craniosynostosis.Hand in glove: brain and skull in development and dysmorphogenesis.Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.Tracheal cartilaginous sleeves in children with syndromic craniosynostosis.Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.PRMT5 is essential for the maintenance of chondrogenic progenitor cells in the limb bud.Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis.Genetic advances in craniosynostosis.Atypical Skin Manifestations in -Related Craniosynostosis Syndromes Broaden the Phenotypic Spectrum
P2860
Q26784240-CA015A5A-0FC8-401A-A314-82B6773D503EQ28066570-83729B2F-3D28-484D-A882-ADE38E94E84EQ30583934-7F8B7251-BECA-4518-9A67-CD15AB864AB4Q33600186-FA6FF28E-ABE3-4F6A-9DE3-9ACC3E366D56Q35755137-BA983BA0-C769-4832-A942-453135AB60DEQ35809894-AB38BB8E-6444-4F7A-8699-8C715558A08BQ36350944-3475B166-2D32-4408-AF98-407BA23CC399Q38032780-25C63C1D-79C4-4E4A-BB63-FA370AA88CEDQ38092652-6CCA5DA7-9D4C-462F-98B5-6CD47F8ABF99Q38605457-19D10BFB-FB6B-4301-97D3-98469AFCB04DQ38845047-E07A02CF-DD42-463F-90E7-0F03B0BA509DQ38849982-FC98C99A-48C5-4E43-A53D-D30E6AC2480CQ46460529-29DD5ED9-FE5E-46FA-B591-ABC2C91CD324Q47166239-6894E2CD-D87C-4697-89B0-0B9F19DA4FF1Q52795305-3CDCEEE4-D666-4A56-985C-0F9E3C8143D2Q56262975-7A54C027-C29A-40ED-9C96-EFE8588D2309
P2860
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@ast
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@en
type
label
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@ast
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@en
prefLabel
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@ast
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@en
P2093
P2860
P50
P356
P1476
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
@en
P2093
Amélie Rezza
David L Huso
Greg Holmes
Jenna Friedenthal
Joan T Richtsmeier
Kurun Oberoi
Robert Phelps
Ross Couwenhoven
Xueyan Zhou
P2860
P304
P356
10.1172/JCI62644
P407
P577
2012-05-15T00:00:00Z